Previous studies have shown that blood-contacting materials activate blood
monocytes. The aim of this study is to evaluate a highly sensitive techniqu
e for detecting changes at the mRNA level in circulating monocytes and to f
ind suitable "gene markers" for assessing the hemocompatibility of biomater
ials. Human blood was recirculated in a modified Chandler Loop formed of te
st tubes. Five groups of biomaterials were compared. Monocytes were separat
ed by using magnetic beads, and gene expression analyses were performed usi
ng RT-PCR. We investigated the mRNA expression of stress proteins (hsp70) a
nd inflammatory markers (IL-1 alpha, IL-1 beta, IL-6, TNF-alpha). mRNAs for
cytokines were highly upregulated in LPS-stimulated monocytes. Hsp70 trans
cripts were upregulated after heat shock but were not influenced by treatme
nt with LPS. The gene expression of the cytokines was affected by various b
iomaterials. The intensity of the inflammatory response increased in the fo
llowing order: heparin coatings (PVC) < uncoated PVC < silicone, polypeptid
e-coated PVC. No change was seen in the expression of the hsp70 genes. An i
nhibitory effect of systemic heparin on surface-activated monocytes was obs
erved for the mRNA expression of the cytokines. The recirculation of human
blood in an in vitro model in combination with the immunomagnetic separatio
n of monocytes and the Duplex RT-PCR method is a powerful tool for getting
reliable results. Our data demonstrate that hsp70 genes cannot be recommend
ed for short-term, biomaterial-induced mRNA expression studies. Conversely,
mRNAs for IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha were expressed in a m
aterial-dependent manner. Thus om model provides an effective tool for asse
ssing the hemocompatibility of biomaterials before their clinical applicati
on and it also can serve as a safety control during the industrial manufact
uring process. This method can be applied to various blood cell populations
and numerous gene expression studies and may enable a more fundamental und
erstanding of the biologic processes involved in blood-material interaction
s. (C) 2001 John Wiley & Sons, Inc.